sv se

The clinical study in bacterial vaginosis was conducted at two gynecology clinics in Skåne in 2019. A total of 24 patients with bacterial vaginosis were included according to the acknowledged Amsel criteria (at least 3 out of 4 Amsel criteria for diagnosis). Patients were treated with pHyph days 0, 2, 4 and 6 and if they were not clinically healthy at the follow-up visit on day 7, treatment continued on days 7, 9, 11 and 13. Patients were aged 18-49 and the median age 33 years.

 

82 % of patients were clinically cured (none of the three Amsel Criteria) at day 7. There were no SAE (serious adverse events) and no unexpected AE (adverse events). The full results will be presented at a scientific conference in spring 2020.

kartaGedea Biotech AB
Medicon Village
Scheelevägen 2
223 81 Lund
Sweden
Annette Säfholm, CEO
annette.safholm@gedeabiotech.com
+46 (0) 708 - 91 86 81

Privacy Policy
nyhetsbrev
Eit